Sandra Alandes
YOU?
Author Swipe
View article: Data from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Data from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Progression on therapy in non-small cell lung carcinoma (NSCLC) is often evaluated radiographically, however, image-based evaluation of said therapies may not distinguish disease progression due to intrinsic tumor drug resistance or ineffi…
View article: Supplementary Figure Legend from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Supplementary Figure Legend from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Supplementary Figure Legend
View article: Supplementary Materials and Methods from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Supplementary Materials and Methods from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Supplementary Materials and Methods
View article: Supplementary Figure S1-S5 from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Supplementary Figure S1-S5 from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Supplementary Figure S1-S5
View article: Data from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Data from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Progression on therapy in non-small cell lung carcinoma (NSCLC) is often evaluated radiographically, however, image-based evaluation of said therapies may not distinguish disease progression due to intrinsic tumor drug resistance or ineffi…
View article: Supplementary Materials and Methods from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Supplementary Materials and Methods from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Supplementary Materials and Methods
View article: Supplementary Figure S1-S5 from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Supplementary Figure S1-S5 from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Supplementary Figure S1-S5
View article: Supplementary Figure Legend from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
Supplementary Figure Legend from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma Open
Supplementary Figure Legend
View article: Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice Open
View article: Endothelin-1–Mediated Drug Resistance in <i>EGFR</i> -Mutant Non-Small Cell Lung Carcinoma
Endothelin-1–Mediated Drug Resistance in <i>EGFR</i> -Mutant Non-Small Cell Lung Carcinoma Open
Progression on therapy in non-small cell lung carcinoma (NSCLC) is often evaluated radiographically, however, image-based evaluation of said therapies may not distinguish disease progression due to intrinsic tumor drug resistance or ineffi…